IP Library Patent Application 16745428
Patent Application
App. No. 16/745,428

Delivery of Halogens to a Subterranean Formation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/745,428
Abstract

Compositions and methods for treating kerogen in a subterranean formation by generating bromine and other halogens in situ in a subterranean formation. In some implementations, the generation of the bromine or halogen is delayed. This can occur, for example, by the decomposition of precursors, a chemical reaction, the encapsulation of precursors or reactants, or a combination of these approaches.

Claims (22)

1 . A composition for treating kerogen in a subterranean formation, comprising:

a fracturing fluid; and

at least one N-halosuccinimide selected from a group consisting of N-bromosuccinimide, N-chlorosuccinimde, and N-iodosuccinimide,

wherein the N-halosuccinimide is dissolved in the fracturing fluid, and wherein the N-halosuccinimide is present in the fracturing fluid at a concentration of 0.001M to 0.10M.

2 . The composition of claim 1 , wherein the fracturing fluid is an aqueous-based fracturing fluid.

3 . The composition of claim 1 , wherein the fracturing fluid is a carbon-dioxide based fluid.

4 . A composition for treating kerogen in a subterranean formation, comprising:

a polymer;

at least one N-halosuccinimide selected from a group consisting of N-bromosuccinimide, N-chlorosuccinimide, and N-iodosuccinimide, wherein the N-halosuccinimide is encapsulated in the polymer; and

carbon dioxide-based fluid.

5 . The composition of claim 4 , wherein the polymer is a polymer matrix selected from a group consisting of polyvinyl butyral polymer, vinyl acetal polymer, butyral polymer, styrene/-maleic anhydride copolymer, and alkylated vinylpyrrolidone copolymer.

6 . The composition of claim 4 , wherein the polymer is an enteric coating selected from a group consisting of methylacrylate-methacrylic acid copolymers, cellulose acetate phthalate, cellulose acetate succinate, hydroxypropylmethyl cellulose phthalate, hypromellose acetate succinate, polyvinyl acetate phthalate, shellac, cellulose acetate trimellitate, sodium alginate, and zein.

7 . The composition of claim 4 , wherein the encapsulated N-halosuccinimide is dissolved in the carbon dioxide-based fluid at a concentration of 5 to 100 pounds of encapsulated N-halosuccinimide per 1000 gallons of carbon dioxide-based fluid.

8 . A method for treating kerogen in a subterranean formation, comprising

dissolving at least one N-halosuccinimide selected from a group consisting of N-bromosuccinimide, N-chlorosuccinimide, and N-iodosuccinimide in a fracturing fluid to create an N-halosuccinimide solution; and

flowing the N-halosuccinimide solution into a subterranean formation at which kerogen is present.

9 . The method of claim 8 , wherein the dissolving at least one N-halosuccinimide in a fracturing fluid comprises dissolving at least one N-halosuccinimide in the fracturing fluid at a concentration of 0.001M to 0.10M.

10 . The method of claim 8 , wherein the fracturing fluid is an aqueous-based fracturing fluid.

11 . The method of claim 8 , wherein the fracturing fluid is a carbon dioxide-based fracturing fluid.

12 . The method of claim 11 , further comprising encapsulating at least one N-halosuccinimide before dissolving the N-halosuccinimide in the fracturing fluid, wherein the encapsulated N-halosuccinimide is dissolved in the fracturing fluid at a concentration of 1 to 100 pounds of encapsulated N-halosuccinimide per 10000 gallons of fracturing fluid.

13 . The method of claim 12 , wherein encapsulating the N-halosuccinimide further comprises encapsulating the N-halosuccinimide in a polymer matrix selected from a group consisting of polyvinyl butyral, vinyl acetal polymer, butyral, styrene/-maleic anhydride copolymer, and alkylated vinylprrolidone copolymer.

14 . The method of claim 12 , wherein encapsulating the N-halosuccinimide further comprises encapsulating the N-halosuccinimide in an enteric coating selected from a group consisting of methylacrylate-methacrylic acid copolymers, cellulose acetate phthalate, cellulose acetate succinate, hydroxypropylmethyl cellulose phthalate, hypromellose acetate succinate, polyvinyl acetate phthalate, shellac, cellulose acetate trimellitate, sodium alginate, and zein.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2020
From: ARAMCO SERVICES COMPANY
To: SAUDI ARAMCO UPSTREAM TECHNOLOGY COMPANY
Reel/Frame 052509/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2020
From: SAUDI ARAMCO UPSTREAM TECHNOLOGY COMPANY
To: SAUDI ARABIAN OIL COMPANY
Reel/Frame 052509/0399 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2020
From: SCHIPPER, DESMOND; HULL, KATHERINE LEIGH; ABOUSLEIMAN, YOUNANE N.
To: ARAMCO SERVICES COMPANY
Reel/Frame 051548/0943 →